Process for differential diagnosis of Alzheimer's dementia and device therefor
US6451547B1 · kind B1 · utility
9Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2001 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Apr 25, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for diagnosing Alzheimer's disease(AD) is disclosed. The method involves directly detecting the presence of a biochemical marker, specifically human glutamine synthetase, in bodily fluid, preferably blood or a blood product. The detection is by an immunoassay incorporating an antibody specific to human glutamine synthetase. In addition, a method for distinguishing between AD and non-AD dementia is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.